Update: We are still processing DNA kits safely and there is no delay or reduction of service at this time.

FDA AUTHORIZED REPORTS INCLUDED

Ancestry + Traits Service

Price:$99
FDA AUTHORIZED REPORTS INCLUDED

Ancestry + Traits Service

The best DNA kit with the most comprehensive ancestry breakdown and 30+ trait reports.

  • 80+ personalized reports
  • Ancestry percentages (to the 0.1%)
  • 2000+ geographic regions
  • Health upgrade available

Add to cart

Price:$99
Ancestry + Traits Service
Add to cart
Price:$99
Add to cart

Ancestry + Traits.
It's even better with
Health.

Choose the Health + Ancestry Service and discover how your DNA can empower you with insights to help you take action on your health and wellness.

FeatureAncestry + Traits ServiceHealth + Ancestry ServiceVIP Health + Ancestry Service

Ancestry + Traits
Service

Price:$99
Add to cart
Recommended

Health + Ancestry
Service

Price:$199
Add to cartImportant test info

VIP Health + Ancestry Service

Price:$499
Add to cartImportant test info
Total Reports80+150+150+
Ancestry Reportsincludedincludedincluded
Family Treeincludedincludedincluded
DNA Relative Finder
includedincludedincluded
Trait Reports
includedincludedincluded
Health Predisposition Reports*
not includedincludedincluded
Carrier Status Reports*
not includedincludedincluded
Wellness Reports
not includedincludedincluded
VIP features
not includednot includedincluded
Customer Stories

Putting insights into action

Whether it’s connecting with distant relatives or experiencing the cultures where they’re from, our customers aren’t just loving what they’ve learned. They’re living it!

Watch Angelina's story

Watch Angelina's story

Finding peace in her identity

Watch Jordan's story

Watch Jordan's story

A pathway to a stronger sense of himself

More insights are
on the way.

Guess what? You're just getting started. As we continue to make discoveries, you'll continue to be able to get more. More specificity. More interactivity. More insights into what makes you, you.

Customer Reviews

Don’t take our word for it...

Stay in the know.

Keep up-to-date with new discoveries and exclusive promotions on our DNA test kits.

*The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and the 23andMe Type 2 Diabetes health predisposition report which is based on 23andMe research and has not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/

Priority lab processing, premium customer support and 30-minute phone ancestry results walkthrough are valid for 1 year from the date of purchase.